Esmaeili, S. and Zabeti, A. 2023. Ocrelizumab-induced Psoriasis in A Patient with Relapsing-Remitting Multiple Sclerosis. European Journal of Medical and Health Sciences. 5, 3 (May 2023), 1–2. DOI:https://doi.org/10.24018/ejmed.2023.5.3.1697.